Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-EN Version v3-EN
Language English English
Date Updated 2018-09-13 2018-05-26
Drug Identification Number 02387433 02387433
Brand name YAZ PLUS YAZ PLUS
Common or Proper name drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium tablets drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium tablets
Company Name BAYER INC BAYER INC
Ingredients DROSPIRENONE Levomefolate Calcium ETHINYL ESTRADIOL DROSPIRENONE Levomefolate Calcium ETHINYL ESTRADIOL
Strength(s) 3.00MG 0.451MG 0.02MG 3.00MG 0.451MG 0.02MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 28's 28's
ATC code G03AA G03AA
ATC description HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2018-05-25 2018-05-25
Actual start date
Estimated end date 2018-09-25 2018-08-31
Actual end date 2018-09-12
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product available in the market.
Health Canada comments